NEVVI Medicare utilization intelligence

← back

Provider profile

MONTERO, RAQUEL

Nurse Practitioner · NPI 1508330630 · YUBA CITY, CA

1
Groups
19
Codes · 2024
4,745
Disclosed services

MONTERO, RAQUEL is a Nurse Practitioner in YUBA CITY, CA, a member of 1 medical group, who billed 19 distinct codes to Medicare Part B in 2024.

Groups: SUTTER VALLEY MEDICAL FOUNDATION (SACRAMENTO, CA)

Year: 2024 · 2023 · 2022 🔒 · 2021 🔒 · 2020 🔒

Provider overview · all codes · CY2024

4,745
disclosed services
19
codes billed to Medicare Part B
Prior year · CY2023 4,055 disclosed services

This provider's disclosed Medicare payments across all codes were premium in CY2024.

Dollars, place-of-service mix, business mix and national standing are part of the market analytics platform — built, not launched yet. Notify me at launch →

All figures are disclosed (CMS suppresses fewer-than-11-beneficiary rows) Medicare Part B fee-for-service — a subset, never complete totals; volumes are personal to this NPI, not attributed to any group. Standing is a billed-volume position among specialty peers with disclosed billing (national percentile; a provider's true standing can only be higher, never lower), not a statement about care. See Methods & Sources.

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
This provider's Medicare volumes — services, beneficiary-episodes, and charges — are part of the market analytics platform — built, not launched yet. Notify me at launch →
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J0897 Injection, denosumab, 1 mg premiumpremium premiumpremium
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more premiumpremium premiumpremium
96372 Injection of drug or substance under skin or into muscle premiumpremium premiumpremium
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg premiumpremium premiumpremium
J1100 Injection, dexamethasone sodium phosphate, 1 mg premiumpremium premiumpremium
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg premiumpremium premiumpremium
J1885 Injection, ketorolac tromethamine, per 15 mg premiumpremium premiumpremium
G0008 Administration of influenza virus vaccine premiumpremium premiumpremium
J0696 Injection, ceftriaxone sodium, per 250 mg premiumpremium premiumpremium
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more premiumpremium premiumpremium
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes premiumpremium premiumpremium
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes premiumpremium premiumpremium
90653 Influenza vaccine, inactivated premiumpremium premiumpremium
99239 Hospital discharge day management, more than 30 minutes premiumpremium premiumpremium
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit premiumpremium premiumpremium
99496 Transitional care management services for problem of high complexity premiumpremium premiumpremium
90656 Influenza vaccine, trivalent, split virus, preservative-free, 0.5 ml dosage premiumpremium premiumpremium
90677 Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use premiumpremium premiumpremium
G0009 Administration of pneumococcal vaccine premiumpremium premiumpremium

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.